February 6th 2025
Favorable bleeding outcomes related to abelacimab have positioned the medication as a potential game changer in the treatment of atrial fibrillation.
A Decade of Progress in Familial Hypercholesterolemia Awareness, Treatment
FDA Expands Omnipod 5 AID System Label to Treat Type 2 Diabetes